Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein
O Lefebvre, MP Chenard, R Masson, J Linares… - Science, 1996 - science.org
To determine the function of the pS2 trefoil protein, which is normally expressed in the
gastric mucosa, the mouse pS2 (mpS2) gene was inactivated. The antral and pyloric gastric …
gastric mucosa, the mouse pS2 (mpS2) gene was inactivated. The antral and pyloric gastric …
[HTML][HTML] HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing
…, S Arbogast, A Walch, G Monges, MP Chenard… - Virchows Archiv, 2010 - Springer
Trastuzumab-based therapy has been shown to confer overall survival benefit in HER2-positive
patients with advanced gastric cancer in a large multicentric trial (ToGA study). …
patients with advanced gastric cancer in a large multicentric trial (ToGA study). …
Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas.
…, JP Bellocq, N Rouyer, MP Chenard… - Proceedings of the …, 1995 - National Acad Sciences
From breast cancer cDNA libraries, we have cloned cDNAs that proved to correspond to the
membrane-type matrix metalloproteinase (MT-MMP) recently identified in human placenta …
membrane-type matrix metalloproteinase (MT-MMP) recently identified in human placenta …
[HTML][HTML] Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review
…, D Serin, M Spielmann, M Haugh, MP Chenard… - Breast cancer research …, 2012 - Springer
Clinicians can use biomarkers to guide therapeutic decisions in estrogen receptor positive (ER+)
breast cancer. One such biomarker is cellular proliferation as evaluated by Ki-67. This …
breast cancer. One such biomarker is cellular proliferation as evaluated by Ki-67. This …
Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial
Background Chemotherapy is the standard of care for advanced stages of non-small-cell
lung cancer (NSCLC). TG4010 is a targeted immunotherapy based on a poxvirus (modified …
lung cancer (NSCLC). TG4010 is a targeted immunotherapy based on a poxvirus (modified …
In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy
… Régis Masson, Olivier Lefebvre, Agnès Noël, Mostapha El Fahime, Marie-Pierre Chenard,
Corinne Wendling, Florence Kebers, Marianne LeMeur, Andrée Dierich, Jean-Michel Foidart, …
Corinne Wendling, Florence Kebers, Marianne LeMeur, Andrée Dierich, Jean-Michel Foidart, …
Matrix metalloproteinases as stromal effectors of human carcinoma progression: therapeutic implications
P Basset, A Okada, MP Chenard, R Kannan, I Stoll… - Matrix Biology, 1997 - Elsevier
The matrix metalloproteinases (MMPs) are extracellular zinc-enzymes implicated in a
number of physiological and pathological tissue remodeling processes, including cancer …
number of physiological and pathological tissue remodeling processes, including cancer …
STARD 3 mediates endoplasmic reticulum‐to‐endosome cholesterol transport at membrane contact sites
…, B Védie, T Kobayashi, MP Chenard… - The EMBO …, 2017 - embopress.org
St AR ‐related lipid transfer domain‐3 ( STARD 3) is a sterol‐binding protein that creates
endoplasmic reticulum ( ER )–endosome contact sites. How this protein, at the crossroad …
endoplasmic reticulum ( ER )–endosome contact sites. How this protein, at the crossroad …
[HTML][HTML] Presence of a new conserved domain in CART1, a novel member of the tumor necrosis factor receptor-associated protein family, which is expressed in breast …
…, C Tomasetto, C Moog-Lutz, MP Chenard… - Journal of Biological …, 1995 - Elsevier
CART1, a novel human gene, encodes a putative protein exhibiting three main structural
domains: first, a cysteine-rich domain located at the amino-terminal part of the protein, which …
domains: first, a cysteine-rich domain located at the amino-terminal part of the protein, which …
Stromelysin-3 is a potent negative regulator of adipogenesis participating to cancer cell-adipocyte interaction/crosstalk at the tumor invasive front
KL Andarawewa, ER Motrescu, MP Chenard… - Cancer research, 2005 - AACR
The initial invasive processes during cancer development remain largely unknown.
Stromelysin-3/matrix metalloproteinase 11 (ST3/MMP11) is associated with tumor invasion and poor …
Stromelysin-3/matrix metalloproteinase 11 (ST3/MMP11) is associated with tumor invasion and poor …